H&R Block vs Regis
HRB and RGS side by side, both in consumer discretionary. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HRB and RGS compare
H&R Block is the larger company, worth 85 times as much as Regis ($6.3B against $74.1M).
On earnings, H&R Block is cheaper: it trades at 9.1× trailing earnings, against 12.3× for Regis.
Regis grew revenue faster over the last twelve months (6.8% versus 4.9% for H&R Block).
H&R Block keeps more of each dollar of sales as profit, with a net margin of 18.6% compared with 3.1% at Regis.
H&R Block pays a dividend yielding 3.4%; Regis does not pay one.
H&R Block scores higher on the StockData Score (18 against 6 for Regis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HRB | RGS |
|---|---|---|
| Size and price | ||
| Market cap | $6.3B | $74.1M |
| Share price | $51.31 | $29.67 |
| Change, 1 year | 1.0% | −1.4% |
| Change, 5 years | 103% | −46.3% |
| Beta (5Y) | 0.40 | 0.88 |
| Employees | 4,600 | 1,611 |
| StockData Score | ||
| Total score | 18 (better) | 6 |
| Valuation score | 5 | 5 |
| Growth score | 3 (better) | 1 |
| Performance score | 4 (better) | 0 |
| Health score | 3 (better) | 0 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 9.1× (better) | 12.3× |
| P/S | 1.6× | 0.3× (better) |
| P/B | 53.8× | 0.4× (better) |
| EV/EBITDA | 6.5× | 5.8× (better) |
| P/FCF | 8.4× | 6.7× (better) |
| PEG | 0.53 | – |
| FCF yield | 12.0% | 15.0% (better) |
| Fair value | $78.19 | $53.04 |
| Margin of safety | 34.4% | 44.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.9% | 6.8% (better) |
| Revenue growth, 5Y average | 8.4% (better) | −11.4% |
| Net income growth (TTM) | 21.1% (better) | −94.4% |
| EPS growth (TTM) | 28.9% | – |
| Profitability | ||
| Gross margin | 44.3% | – |
| Operating margin | – | 10.9% |
| Net margin | 18.6% (better) | 3.1% |
| FCF margin | 19.2% (better) | 5.0% |
| Return on equity | 711% (better) | 3.7% |
| Return on invested capital | – | 8.7% |
| Financial health | ||
| Debt / equity | 12.69 | 0.60 (better) |
| Net debt / EBITDA | 0.50 (better) | 3.22 |
| Interest coverage | – | 1.2× |
| Current ratio | 1.13 (better) | 0.62 |
| Altman Z-score | 2.48 (better) | 0.89 |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 3.4% | – |
| Payout ratio | 28.8% | – |
| Years of dividend growth | 4 | – |
| Dividend growth, 5Y average | 10.1% | – |
| Buyback yield | – | −0.82% |
| Shareholder yield | 3.4% (better) | −0.82% |
| Ownership | ||
| Held by institutions | 104% | 31.0% |
| Held by insiders | 1.7% | 10.3% |
| Insider net buying, 12 months | −$13.9M | −$14.0K (better) |
| Short interest, % of float | 15.3% | 2.0% |
Go deeper
- HRB stock overview
- HRB income statement
- HRB valuation and score
- RGS stock overview
- RGS income statement
- RGS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.